Analysis of a high-throughput HLA antibody screening assay for use with platelet donors

Transfusion

Volumn 48, Issue 6, 2008, Pages 1174-1179

  Fadeyi, Emmanuel ^b   Adams, Sharon ^b   Peterson, Brett ^b   Hackett, Julia ^b   Byrne, Phyllis ^b   Klein, Harvey G ^b   Marincola, Francesco M ^b   Leitman, Susan F ^b   Stroncek, David F ^a,b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIBODY; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA CLASS 1 ANTIBODY; HLA CLASS 2 ANTIBODY;

ANALYZER; ANTIBODY DETECTION; ANTIBODY SCREENING; ARTICLE; BLOOD DONOR; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH THROUGHPUT SCREENING; HUMAN; IMMUNOREACTIVITY; INTERMETHOD COMPARISON; MALE; THROMBOCYTE; THROMBOCYTOPHERESIS;

ANTIBODIES; BLOOD DONORS; BLOOD PLATELETS; FEMALE; HLA ANTIGENS; HUMANS; IMMUNOASSAY; MALE; MICROSPHERES; PLATELET TRANSFUSION;

EID: 44849132885     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2008.01684.x     Document Type: Article

References (14)

1. Goldman M, Webert KE, Arnold DM, Freedman J, Hannon J, Blajchman MA. Proceedings of a consensus conference: towards an understanding of TRALI. Transfus Med Rev 2005 19 : 2 31.
2. Fadeyi EA, Los Angeles MM, Wayne AS, Klein HG, Leitman SF, Stroncek DF. The transfusion of neutrophil-specific antibodies causes leukopenia and a broad spectrum of pulmonary reactions. Transfusion 2007 47 : 545 50.
3. Kleinman S, Gajic O, Nunes E. Promoting recognition and prevention of transfusion-related acute lung injury. Crit Care Nurse 2007 27 : 49 53.
4. Itoh Y, Mizuki N, Shimada T, Azuma F, Itakura M, Kashiwase K, Kikkawa E, Kulski JK, Satake M, Inoko H. High-throughput DNA typing of HLA-A, -B, -C, and -DRB1 loci by a PCR-SSOP-Luminex method in the Japanese population. Immunogenetics 2005 57 : 717 29.
5. Itoh Y, Inoko H, Kulski JK, Sasaki S, Meguro A, Takiyama N, Nishida T, Yuasa T, Ohno S, Mizuki N. Four-digit allele genotyping of the HLA-A and HLA-B genes in Japanese patients with Behcet's disease by a PCR-SSOP-Luminex method. Tissue Antigens 2006 67 : 390 4.
6. Pei R, Wang G, Tarsitani C, Rojo S, Chen T, Takemura S, Liu A, Lee J-H. Simultaneous HLA Class I and Class II antibodies screening with flow cytometry. Hum Immunol 1998 59 : 313 22.
7. Pei R, Lee J, Chen T, Rojo S, Terasaki PI. Flow cytometric detection of HLA antibodies using a spectrum of microbeads. Hum Immunol 1999 60 : 1293 302.
8. Pei R, Lee JH, Shih NJ, Chen M, Terasaki P. Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antigen antibody specificities. Transplantation 2003 75 : 43 9.
9. Eder AF, Chambers LA. Noninfectious complications of blood transfusion. Arch Pathol Lab Med 2007 131 : 708 18.
10. Silliman CC, Boshkov LK, Mehdizadehkashi Z, Elzi DJ, Dickey WO, Podlosky L, Clarke G, Ambruso DR. Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors. Blood 2003 101 : 454 62.
11. Khan SY, Kelher MR, Heal JM, Blumberg N, Boshkov LK, Phipps R, Gettings KF, McLaughlin NJ, Silliman CC. Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury. Blood 2006 108 : 2455 62.
12. Silliman CC, Curtis BR, Kopko PM, Khan SY, Kelher MR, Schuller RM, Sannoh B, Ambruso DR. Donor antibodies to HNA-3a implicated in TRALI reactions prime neutrophils and cause PMN-mediated damage to human pulmonary microvascular endothelial cells in a two-event in vitro model. Blood 2007 109 : 1752 5.
13. Gibney EM, Cagle LR, Freed B, Warnell SE, Chan L, Wiseman AC. Detection of donor-specific antibodies using HLA-coated microspheres: another tool for kidney transplant risk stratification. Nephrol Dial Transplant 2006 21 : 2625 9.
14. Peters B, Whittall T, Babaahmady K, Gray K, Vaughan R, Lehner T. Effect of heterosexual intercourse on mucosal alloimmunisation and resistance to HIV-1 infection. Lancet 2004 363 : 518 24.